Ledazerol

This classification denotes a vasodilating agent with the molecular formula C11H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P13OO3FPZB, chemically known as benzenemethanol, 2-hydroxy-3-(1h-imidazol-4-ylmethyl)- but generally known as ledazerol, which bears US NIH Compound Identifier 65932. European Medicines Agency schedules Ledazerol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08420MIG. The term LEDAZEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). LEDAZEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ledazerol under HS 29332990 and SITC 51573. As of Q4 2014, LEDAZEROL remains the US FDA Preferred Term for this commodity. Ledazerol bears US NLM identifiers UMLS ID C2825585 and NCI Concept Code C81348. SMILES: C1=CC(=C(C(=C1)CO)O)CC2=CN=CN2.